sameAs
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesCurrent ebola vaccinesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesEbola Vaccination: If Not Now, When?A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAPhase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeChimpanzee Adenovirus Vector Ebola Vaccine — Preliminary ReportA Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportClinical development of Ebola vaccinesEbolavirus Vaccines: Progress in the Fight Against Ebola Virus DiseaseEbola virus vaccines: an overview of current approachesOptimal control analysis of Ebola disease with control strategies of quarantine and vaccinationAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccineVaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsToxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-InsertsBiodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene InsertsEfficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Development of a preventive vaccine for Ebola virus infection in primatesAcceptability and Willingness-to-Pay for a Hypothetical Ebola Virus Vaccine in NigeriaA two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaksA review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?[Back to the Future. Vaccine trials against Ebola in the history of resistance to immunization].Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysisProgress of vaccine and drug development for Ebola preparednessEbola hemorrhagic Fever and the current state of vaccine developmentEbola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusEbola virus vaccines: Where do we stand?[Overview of the Ebola vaccines in pre-clinical and clinical development].Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in MiceThe Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014-2016 Ebola outbreak in West Africa.The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?In silico-based vaccine design against Ebola virus glycoproteinEnhanced protection against Ebola virus mediated by an improved adenovirus-based vaccineMucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic.Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.Ebola Vaccine: How Far are we?Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
P921
Q21131585-A34C88CF-983D-430E-BF84-BC2083BB2415Q21534720-169D3909-97B9-4E7D-93B0-461903448943Q21562420-60370A8F-D7C7-469D-BC30-C84E2E2CB970Q22305299-AD0420C5-92BF-40F6-B0B1-F560E1D00B30Q24289279-0D7C75E2-ED5C-445B-8A54-EEBA6FB2375AQ24289281-83CD903B-C668-4B19-B2A2-626B85197F53Q24289287-E7455315-95A1-47DD-976C-790627B12125Q24289295-F2781B28-7823-438F-AB4A-04F55E75D6CBQ26775792-55A50C95-5627-4E29-A6BD-33F85DA05648Q26780259-A2EF6D5B-BD82-4AC7-9967-722F14B175BCQ26999232-EC996863-1E2C-48F1-8F3D-F367F1930A35Q27318406-7542E0D6-724A-4F8A-A7F2-2403148CCE52Q27334697-D0C5F8B1-6525-48B8-8261-9E19DDC38436Q27485491-E2793128-1D16-4EE2-840A-938E9D3CBB5CQ27485953-09CF40DC-41E8-4860-A30C-65079691048EQ27486035-BF8B31F6-A682-4BBB-92F7-D4941F2CCEF8Q28051937-935BADFA-7B75-4E97-8BC3-942B65EE0F57Q28140401-040628F4-1929-4B03-8B00-9ECD38F4B50EQ28548319-D082FE71-98AC-4A16-80B7-31CF92AEF908Q29048611-5976BC70-26B4-4D18-9F87-B65ACD808409Q29994671-635B07D1-2195-4618-B886-39B1C46688C9Q30151742-CD413D8A-954C-45CC-A9FB-6787E69F3CA5Q30203666-3224F602-5476-4665-B6F6-6C4CAE6FDD6AQ30204075-F4F07B54-C815-410C-AA3A-BC0FAF4D66F8Q30204870-87BC2649-F5A5-4153-ADFC-78DB76093EA2Q30205198-EB4023B7-BC48-48A5-8625-52FCDFC9F958Q30234637-9F787292-6B26-4515-A7F8-B764F899F192Q30235073-9784F4C1-1218-45E6-8869-3A1D38DA979AQ30240265-7EB88E58-CD49-4DDA-B415-5F078BDB84ACQ30245207-C1E93055-6DDA-4B2A-A5D3-DF79EB9FAD12Q30375073-31F9CFE3-4D17-49D0-BC14-4614ECE3A32BQ30386387-A29A63E2-C496-4634-A906-1ADF527F85F9Q30396955-C0F5F0F8-BD04-4B0A-9906-21FE9FACBAD3Q30841328-4B882D9A-348B-44E8-9DA7-79CF2EDA8F5AQ30843053-5EAC233A-10A4-49D6-AD0B-2FED98EE086BQ33434415-91E98353-E17F-49B2-B73B-850CDB63CBB4Q33743800-53FDBFDE-4BB8-443B-9FE5-2DA443BEDE59Q33818337-2100F6ED-3CC4-4C66-8F8D-BEDFB33C27B1Q33831877-56967557-2728-4972-84F7-2D6C243B6B3DQ33850032-2BA5F26A-B6A8-4A01-98D9-7972836A4835
P921
description
Vaccine to prevent Ebola
@en
name
Ebola-Impfstoff
@de
Vaccin contre le virus Ébola
@fr
Vaccine against Ebola
@en
Vắc-xin Ebola
@vi
ebolavaksine
@nn
kontraŭ-ebola vakcino
@eo
type
label
Ebola-Impfstoff
@de
Vaccin contre le virus Ébola
@fr
Vaccine against Ebola
@en
Vắc-xin Ebola
@vi
ebolavaksine
@nn
kontraŭ-ebola vakcino
@eo
altLabel
Ebola vaccine
@en
ebola vakcino
@eo
vakcino kontraŭ ebolo
@eo
vakcino kontraŭ eboloviruso
@eo
vaksine mot ebola
@nn
prefLabel
Ebola-Impfstoff
@de
Vaccin contre le virus Ébola
@fr
Vaccine against Ebola
@en
Vắc-xin Ebola
@vi
ebolavaksine
@nn
kontraŭ-ebola vakcino
@eo
P486
P6366
P1924
P279
P3219
ebola-vaccin-contre-le-virus
P486
P6366
2778933410